Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 60% ± 21% | |
lung | 9 studies | 38% ± 21% | |
heart | 5 studies | 50% ± 15% | |
eye | 5 studies | 64% ± 16% | |
peripheral blood | 4 studies | 37% ± 14% | |
liver | 4 studies | 41% ± 23% | |
bone marrow | 3 studies | 36% ± 23% | |
intestine | 3 studies | 20% ± 2% | |
adipose | 3 studies | 63% ± 22% | |
kidney | 3 studies | 53% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 7641.28 | 1445 / 1445 | 100% | 13.73 | 183 / 183 |
breast | 100% | 10989.15 | 459 / 459 | 99% | 20.60 | 1105 / 1118 |
lung | 100% | 8063.71 | 578 / 578 | 99% | 9.68 | 1138 / 1155 |
stomach | 100% | 5235.94 | 359 / 359 | 98% | 8.26 | 279 / 286 |
intestine | 100% | 6967.57 | 966 / 966 | 97% | 7.04 | 513 / 527 |
thymus | 100% | 7196.49 | 652 / 653 | 97% | 8.04 | 588 / 605 |
prostate | 100% | 5800.64 | 245 / 245 | 97% | 8.91 | 485 / 502 |
kidney | 100% | 3564.67 | 89 / 89 | 96% | 10.90 | 866 / 901 |
uterus | 100% | 10982.11 | 170 / 170 | 95% | 7.11 | 436 / 459 |
brain | 96% | 4340.96 | 2537 / 2642 | 99% | 11.80 | 696 / 705 |
bladder | 100% | 6898.95 | 21 / 21 | 94% | 6.25 | 473 / 504 |
skin | 100% | 11079.82 | 1809 / 1809 | 93% | 7.14 | 440 / 472 |
adrenal gland | 100% | 3583.91 | 257 / 258 | 93% | 4.98 | 214 / 230 |
ovary | 100% | 9242.43 | 180 / 180 | 92% | 5.70 | 397 / 430 |
pancreas | 98% | 3398.59 | 321 / 328 | 94% | 6.43 | 168 / 178 |
liver | 86% | 1790.93 | 195 / 226 | 58% | 2.30 | 235 / 406 |
adipose | 100% | 10501.12 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 9983.38 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 5903.51 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5620.22 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 9.74 | 43 / 45 |
heart | 93% | 3049.40 | 804 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 89% | 5.14 | 71 / 80 |
peripheral blood | 82% | 2821.37 | 760 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 72% | 4.85 | 21 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016592 | Cellular component | mediator complex |
GO_0003712 | Molecular function | transcription coregulator activity |
Gene name | MED13L |
Protein name | Mediator complex subunit 13L Mediator of RNA polymerase II transcription subunit 13 Mediator of RNA polymerase II transcription subunit 13-like (Mediator complex subunit 13-like) (Thyroid hormone receptor-associated protein 2) (Thyroid hormone receptor-associated protein complex 240 kDa component-like) |
Synonyms | TRAP240L PROSIT240 KIAA1025 THRAP2 |
Description | FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. This subunit may specifically regulate transcription of targets of the Wnt signaling pathway and SHH signaling pathway. FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. . FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. . |
Accessions | A0A3B3IS46 ENST00000649607.1 ENST00000649775.1 H0YHC1 ENST00000549786.2 A0A3B3IRS4 A0A3B3IRX3 F8VRB8 A0A3B3IS48 A0A3B3IS36 Q71F56 ENST00000650226.1 ENST00000647567.1 ENST00000551197.2 ENST00000281928.9 ENST00000548743.2 |